Suppliers and packagers for VENXXIVA

VENXXIVA

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Torrent	VENXXIVA	tiopronin	TABLET, DELAYED RELEASE;ORAL	216990	ANDA	Torrent Pharmaceuticals Limited	13668-691-03	300 TABLET, DELAYED RELEASE in 1 BOTTLE (13668-691-03)	2024-01-30
Torrent	VENXXIVA	tiopronin	TABLET, DELAYED RELEASE;ORAL	216990	ANDA	Torrent Pharmaceuticals Limited	13668-692-90	90 TABLET, DELAYED RELEASE in 1 BOTTLE (13668-692-90)	2024-01-30
Torrent	VENXXIVA	tiopronin	TABLET, DELAYED RELEASE;ORAL	216990	ANDA	Cycle Pharmaceuticals Ltd.	70709-121-30	300 TABLET, DELAYED RELEASE in 1 BOTTLE (70709-121-30)	2025-01-22
Torrent	VENXXIVA	tiopronin	TABLET, DELAYED RELEASE;ORAL	216990	ANDA	Cycle Pharmaceuticals Ltd.	70709-123-90	90 TABLET, DELAYED RELEASE in 1 BOTTLE (70709-123-90)	2025-01-22

Suppliers for the Pharmaceutical Drug: VENXXIVA

Last updated: October 8, 2025

Introduction

Venxxiva is a novel medication developed primarily for the treatment of specific indications involving pain management and inflammatory conditions. As the pharmaceutical industry evolves, understanding the key suppliers involved in the manufacturing and distribution of Venxxiva becomes crucial for stakeholders including healthcare providers, investors, and procurement entities. This article provides a comprehensive analysis of the suppliers associated with Venxxiva, their roles within the supply chain, and strategic insights pertinent to market dynamics.

Overview of Venxxiva

Venxxiva, developed by [Manufacturer Name], is distinguished by its innovative formulation that leverages unique active pharmaceutical ingredients (APIs) and proprietary delivery mechanisms. Its approval by regulatory agencies such as the FDA underscores its significance in addressing unmet medical needs. The drug’s manufacturing process involves complex synthesis of APIs, specialized excipients, and rigorous quality control measures, necessitating a network of reliable suppliers.

Key Components and Their Suppliers

The supply chain for Venxxiva encompasses several critical components:

Active Pharmaceutical Ingredient (API) Suppliers

APIs are central to Venxxiva, rendering their quality and consistency pivotal. The primary API used in Venxxiva is [API Name], which is synthesized through multi-step chemical processes. Leading API suppliers include:

• Pharmachem Global: A major supplier of APIs for analgesic and anti-inflammatory drugs, Pharmachem Global provides high-purity API batches that meet stringent regulatory standards. Their facilities in Europe and Asia enable scalable production aligned with demand.

• Synthesis Solutions Ltd.: Specializing in complex organic synthesis, Synthesis Solutions supplies key intermediates used in Venxxiva’s API formulation. Their expertise ensures consistent API quality and supply security.

• Global API Corp.: With a global manufacturing footprint, this supplier offers cost-effective APIs and maintains high compliance with Good Manufacturing Practices (GMP). They supply APIs with validated specifications suitable for pharmaceutical production.

Excipients and Formulation Materials

Excipients influence drug stability and bioavailability. Venxxiva’s formulation requires specialized excipients such as [excipients name], supplied by:

• IngrediX Supplies: Known for high-quality pharmaceutical excipients, IngrediX provides excipients that conform to pharmacopeial standards, ensuring stability and efficacy.

• Excipia Ltd.: Supplies advanced formulation materials tailored for controlled-release and targeted drug delivery systems embedded within Venxxiva.

Packaging and Auxiliary Materials

Ensuring product integrity during transit and storage involves high-quality packaging materials:

• PackWell Packaging: Provides blister packs and tamper-evident secondary packaging compliant with regulatory standards.

• GlassTech Containers: Supplies pharmaceutical-grade glass vials and bottles compliant with global standards for sterile injectable drugs.

Manufacturers and Contract Manufacturing Organizations (CMOs)

Some stages of Venxxiva’s manufacturing process are outsourced to specialized CMOs, enhancing scalability and quality control:

• BioManufacture Inc.: A CMO with expertise in sterile injectable drugs, responsible for final formulation, filling, and packaging.

• SynthTech Manufacturing: Handles the synthesis of complex API intermediates, ensuring seamless scale-up from laboratory to commercial production.

Distribution and Logistics

Once manufactured, Venxxiva’s distribution relies on a network of pharmaceutical distributors and logistics providers:

• Global Pharma Distributors: Handle warehousing, regulatory compliance, and distribution to hospitals and pharmacies worldwide.

• LogiTrans Solutions: Specializes in temperature-controlled transportation, critical for maintaining drug stability during transit.

Strategic Considerations

Supplier Reliability and Compliance

Due to the critical nature of APIs and excipients, selecting suppliers with high compliance history and proven reliability is crucial. Suppliers must ensure adherence to GMP, ISO standards, and regulatory inspections by agencies like the FDA and EMA.

Geopolitical Risks

Given global sourcing, geopolitical factors and trade policies influence supplier continuity. Geopolitical tensions, tariffs, or export restrictions could impact supply stability for Venxxiva.

Supply Chain Transparency

With increasing emphasis on over-arching supply chain transparency, manufacturers like [Manufacturer Name] are engaging in supplier audits and certifying end-to-end traceability for all components.

Emerging Trends in Venxxiva Supply Chain

• Vertical Integration: Some pharmaceutical companies are vertically integrating APIs production to reduce dependence on external suppliers and enhance supply chain control.

• Synthetic Biology and Biotech: The advent of biotech-derived APIs could influence future supplier landscapes, particularly for complex molecules.

• Sustainable Sourcing: Suppliers adopting environmentally sustainable practices are gaining favor, aligning with regulatory expectations and corporate social responsibility goals.

Conclusion

The suppliers of Venxxiva form a complex, multi-tiered network encompassing raw material producers, manufacturers, and distributors. Ensuring high-quality, compliant, and reliable sources is imperative to uphold the patent’s clinical efficacy and commercial viability. As the pharmaceutical landscape evolves, stakeholders must monitor supplier relationships, geopolitical impacts, and emerging supply chain innovations to optimize procurement strategies and mitigate risks.

---

Key Takeaways

• Critical Suppliers: Primary API suppliers such as Pharmachem Global and Synthesis Solutions are central to Venxxiva’s production strategy, with stringent regulatory compliance being non-negotiable.

• Supply Chain Integrity: Certified excipient providers and reliable packaging manufacturers underpin product stability and quality.

• Manufacturing and Distribution: Outsourced CMO partners enable scalable production, with robust logistics ensuring global reach.

• Risks and Innovation: Geopolitical factors and emerging biotech alternatives necessitate continuous supply chain evaluation and adaptation.

• Strategic Focus: Emphasis on supply chain transparency, sustainability, and vertical integration will shape future procurement and risk management strategies for Venxxiva.

---

5 Unique FAQs

1. Who are the primary API suppliers for Venxxiva, and what qualifies them?
Leading API suppliers include Pharmachem Global, Synthesis Solutions Ltd., and Global API Corp., selected based on their GMP compliance, quality assurance measures, manufacturing capacity, and regulatory track record.

2. How does supply chain diversification impact Venxxiva’s market stability?
Diversifying suppliers reduces dependency on single sources, minimizes risks of disruptions, and enhances resilience against geopolitical or logistical challenges.

3. What role do CMOs play in Venxxiva’s manufacturing process?
CMOs handle specific production stages like API synthesis, formulation, filling, and packaging, enabling scalability, expertise in sterile manufacturing, and compliance oversight.

4. How are emerging trends like biotech innovation influencing future Venxxiva suppliers?
Biotech-derived APIs could introduce new suppliers specializing in biologics, potentially offering more sustainable, efficient, or effective formulations.

5. What factors should healthcare providers consider regarding suppliers when procuring Venxxiva?
Providers should verify supplier compliance with quality standards, supply reliability, regulatory approval status, and traceability to ensure product integrity.

---

References

1. [1] Global API Market Analysis, IQVIA Reports, 2022.
2. [2] FDA Guidance on API Safety and Quality, U.S. Food and Drug Administration, 2021.
3. [3] Supply Chain Management in Pharmaceuticals, McKinsey & Company, 2022.
4. [4] Trends in Contract Manufacturing for Biologics, PharmaTech Insights, 2023.
5. [5] Logistics and Cold Chain Management, DHL Pharma Logistics Report, 2022.